Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive, fatal motor neuron disease with a variable natural history. There are no accurate models that predict the disease course and outcomes, which complicates risk assessment and counselling for individual patients, stratification of patients for trials, and timing of interventions. We therefore aimed to develop and validate a model for predicting a composite survival endpoint for individual patients with ALS.
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
Calvo, Andrea;Chiò, Adriano;
2018-01-01
Abstract
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive, fatal motor neuron disease with a variable natural history. There are no accurate models that predict the disease course and outcomes, which complicates risk assessment and counselling for individual patients, stratification of patients for trials, and timing of interventions. We therefore aimed to develop and validate a model for predicting a composite survival endpoint for individual patients with ALS.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Lancet Neurol 2018 - Westeneng - Prognosis-for-patients-with-amyotrophic-lateral-sclerosis.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
367.56 kB
Formato
Adobe PDF
|
367.56 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
